クイックアンサー — テサモレリンとは?
Tesamorelin is a peptide supplied as a lyophilized powder for reconstitution. The information on this page describes published preclinical and early clinical literature; it is not medical advice or dosing guidance. Read our linked guide for the complete evidence summary.
テサモレリンペプチド
Tesamorelin is a synthetic growth hormone–releasing hormone (GHRH) analog developed for studies involving endocrine modulation, growth hormone dynamics, and metabolic regulation. It binds to GHRH receptors in the anterior pituitary, stimulating controlled growth hormone secretion and downstream insulin-like growth factor-1 (IGF-1) signaling pathways. This mechanism makes it a valuable compound for studying lipid metabolism, body composition pathways, and hormonal regulation of adipose tissue in clinical models. Study applications include investigations into visceral fat signaling, metabolic efficiency, and age-related changes in GH activity. Its receptor-specific action provides a structured framework for examining hypothalamic-pituitary interactions and growth hormone–mediated metabolic processes in controlled clinical settings.
製品概要
Tesamorelin is a synthetic peptide classified as a stabilized growth hormone–releasing hormone (GHRH) analog intended strictly for clinical investigation. The Tesamorelin peptide features the molecular formula C221H366N72O67S and a molar mass of 5136 g/mol, reflecting its extended amino acid structure engineered for receptor specificity. This lyophilized Tesamorelin is supplied in sterile vials containing 2 mg, 5 mg, 10 mg, or 20 mg of total active ingredient in high purity lyophilized form. Image alt text: lyophilized Tesamorelin peptide vial 10mg high purity compound. Designed for stability under controlled storage conditions, Tesamorelin for studies maintains integrity for up to 36 months when stored as recommended.
Published Evidence
Tesamorelin is utilized in experimental clinical settings focused on endocrine signaling and metabolic pathway analysis. In vitro studies frequently evaluate receptor-binding affinity and downstream intracellular responses following GHRH receptor activation. Pre-clinical models employ the Tesamorelin peptide to investigate growth hormone pulsatility and IGF-1–associated signaling cascades. Users also examine lipid metabolism markers and adipose tissue signaling responses under controlled clinical conditions. Lyophilized Tesamorelin provides consistency for comparative clinical investigation across endocrine-focused study designs. Its defined molecular profile supports reproducible experimentation in regulated studies environments.
再構成と取り扱い
Lyophilized Tesamorelin should be reconstituted using bacteriostatic water under strict aseptic technique within a controlled clinical environment. The diluent should be introduced slowly along the inner vial wall to preserve peptide stability and minimize agitation. Avoid shaking the vial; instead, gently swirl until the solution becomes clear and fully dissolved. Proper handling of the Tesamorelin peptide ensures structural integrity for clinical investigation. After reconstitution, the solution should be refrigerated at 2–8°C and protected from light exposure. All preparation procedures should follow standard clinical practice.
作用機序
Tesamorelin functions as a selective agonist of GHRH receptors located in the anterior pituitary in pre-clinical models. Upon receptor binding, the Tesamorelin peptide stimulates cyclic AMP production and regulated growth hormone secretion within experimental systems. This activation supports downstream IGF-1 signaling pathways that are frequently examined in metabolic and endocrine studies. Tesamorelin for studies demonstrates receptor-targeted activity with minimized off-target interaction in controlled settings. Investigators utilize lyophilized Tesamorelin to analyze feedback mechanisms between hypothalamic and pituitary pathways. These mechanistic properties make it suitable for clinical investigation of growth hormone–mediated metabolic processes.
用法・用量ガイドライン
Dosing ranges reported in published experimental literature vary depending on the specific in vitro studies or pre-clinical models employed. Concentration ranges are typically selected to evaluate receptor activation thresholds and hormonal response markers. In clinical investigation settings, dosing parameters are adjusted according to study endpoints and analytical objectives. Tesamorelin should be quantified using calibrated clinical equipment to ensure precision and reproducibility. Final protocol design remains the responsibility of qualified users operating under institutional compliance standards.
Potential Benefits
- 成長ホルモン受容体活性化マーカーの評価
- IGF-1シグナル伝達経路応答の評価
- 組織モデルにおける脂質代謝指標の観察
- 模擬生体環境での安定性試験
- 内分泌フィードバックループ動態の解析
実験的観察
Experimental observations of the Tesamorelin peptide in vitro studies demonstrate measurable receptor-mediated signaling activity. Clinical findings indicate consistent structural stability of lyophilized Tesamorelin when stored under recommended conditions. Pre-clinical models report reproducible endocrine response patterns aligned with GHRH receptor stimulation. Tesamorelin has shown predictable receptor interaction potential in controlled assays. Investigators note reliable activation of downstream signaling cascades relevant to metabolic pathway analysis. These findings reinforce its applicability in structured endocrine clinical investigation.
Considerations
Users utilizing the Tesamorelin peptide should ensure precise environmental controls to prevent degradation or contamination. Verification of peptide identity and batch consistency is recommended for advanced analytical studies. Lyophilized Tesamorelin must be handled exclusively by trained clinical personnel familiar with peptide protocols. Appropriate documentation and regulatory approvals should be secured prior to experimental use. Tesamorelin should remain confined to designated clinical facilities at all times. Careful procedural planning supports reproducibility and data integrity in experimental clinical settings. Standard clinical protective equipment should be worn during handling and preparation. Avoid inhalation, ingestion, or direct contact with skin and eyes. Dispose of all materials in accordance with institutional biosafety regulations. Users are responsible for compliance with applicable local, national, and international guidelines governing peptide studies. The information provided is for educational and scientific reference and should not be interpreted as medical advice or as a recommendation for any form of administration. Users should follow all applicable regulations and institutional guidelines when handling this material.
保管方法
For long-term preservation, Tesamorelin peptide should be stored at −20°C to maintain molecular stability. Short-term storage may be maintained at 2–8°C under refrigeration. Lyophilized Tesamorelin should be protected from light to prevent degradation. Avoid repeated freeze-thaw cycles, as they may compromise structural integrity and experimental consistency. When stored according to recommended guidelines, the shelf life is 36 months. Proper storage ensures Tesamorelin for studies maintains quality for extended clinical use.
純度と品質
All Tesamorelin vials stocked by MedsBase are supplied at 99%+ HPLC purity in lyophilized form. A certificate of analysis (COA) is available on request — message our support team after placing your order and we will forward the batch-specific COA for the vials you received. It is sold. Some peptides in this class have been used in early-phase clinical trials but no major regulator has issued a marketing authorization for the indications discussed in the popular literature.
テサモレリンはどのように溶解(再構成)しますか?
凍結乾燥ペプチドは通常、計画した用量に適した濃度で、注射用静菌水または注射用滅菌水(BWFI/SWFI)を用いて溶解します。希釈液はバイアルの内壁に沿ってゆっくりと加えてください。粉末の塊に直接水流を当てたり、激しく振ったりしないでください。いずれもペプチドを変性させます。完全に溶解するまで静かに旋回させてください。再構成後のペプチドは通常、2~8°Cで冷蔵保管します。
テサモレリンはどのように保管すべきですか?
凍結乾燥バイアルは、直射日光を避け、−20°Cまたは2~8°Cの冷蔵で保管すると長期間安定です。再構成後、ほとんどのペプチドは緩衝液や特定のペプチドによりますが、冷蔵で14~30日間安定です。バイアルに同梱されている分析証明書を必ず読み、供給元が推奨する保管および安定性データを確認してください。
What does the published literature shows?
The published literature on Tesamorelin is summarized in our linked guide. We separate preclinical (rodent / cell-culture) data, where it is consistent and reproducible, from clinical-trial data, where evidence is typically thinner. We also flag where popular online claims outrun the published record.
Tesamorelinの国際注文は合法ですか?
Peptides occupy an ambiguous regulatory space. Importation rules vary by country and have changed in several jurisdictions over the past few years. It is the buyer’s responsibility to confirm import legality in their destination country before ordering. MedsBase ships peptides worldwide via our dedicated peptide courier; orders that contravene the destination country’s import rules may be detained at customs.
Tesamorelinの半減期はどのくらいですか?
Tesamorelin has a plasma half-life of approximately 26–38 minutes in clinical studies of the approved Egrifta formulation — longer than native GHRH(1-44) due to the trans-3-hexenoic acid modification that protects against DPP-IV cleavage. Most protocols use once-daily subcutaneous administration.
TesamorelinはSermorelinとどのように異なりますか?
Tesamorelinは、半減期を延長する脂肪酸修飾を持つ全長GHRH(1-44)アナログであるのに対し、Sermorelinは修飾のない短縮型GHRH(1-29)断片です。TesamorelinはHIV関連リポジストロフィーに対するFDA承認を取得しており、より充実した臨床データセットがあります。どちらも下垂体からのGH放出を刺激しますが、Tesamorelinの方が作用時間がわずかに長くなっています。
Tesamorelinを他のペプチドと一緒に注文できますか?
Yes. Peptide orders are bundled and ship together via our peptide-only courier service. Lyophilized vials are protective for the duration of standard international transit. See our peptide category page for the full stocked range and the “Best Peptides for Recovery” comparison guide for stacking considerations from the published literature.
あなたのプロトコルがテサモレリンのGHRH駆動性GH放出と局所組織修復ペプチドを組み合わせる場合、当社の ペプチドヒーリングスタック (BPC-157 5 mg + TB-500 5 mg + bacteriostatic water) 血管新生+細胞骨格修復の層を1つの小包でカバーします。
Other Peptides for Recovery and Performance
- BPC-157 — Body Protection Compound — tendon, ligament, gut recovery
- TB-500 — Thymosin Beta-4 fragment — soft tissue and vascular recovery
- Ipamorelin — 選択的グレリン作動薬 — コルチゾール/プロラクチンを伴わないクリーンなGHパルス
- CJC-1295 with DAC — 半減期延長型GHRHアナログ
- GHK-Cu — Copper peptide — skin and connective tissue regeneration
参考文献
📖 Learn the science behind this peptide
エビデンスに基づく完全ガイドをお読みください: Tesamorelin — benefits, dosage & the studies. Covers mechanism of action, published study data, typical dosing ranges, reconstitution protocols, stacking considerations, and safety/contraindication notes.
📦 すべてのご注文は、当店の 再発送保証ポリシー — 万が一、20営業日以内に商品が届かない場合は、再発送いたします。
| 仕様 | 詳細 |
|---|---|
| CAS番号 | 218949-48-5 |
| 分子式 | C221H366N72O67S |
| 分子量 | 5135.86 Da |
| 配列 | trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 (GRF 1–44) |
| 形態 | 凍結乾燥粉末(または供給時の形態) |
| 純度 | ≥99%(HPLC検証済み、COAはご要望に応じて提供) |
| 保管方法 | 凍結乾燥品:使用時在庫は2~8℃(冷蔵)に保管。未開封バイアルの長期保管には−20℃。再溶解後:2~8℃で約30日以内に使用。光から保護してください。再溶解液の凍結融解は避けてください。 |
| 溶解性 | 静菌水(推奨)または短時間使用の場合は滅菌水 |














レビュー
まだレビューはありません